Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $732000.0.

  • Mesa Laboratories' Capital Expenditures fell 996.31% to $732000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 million, marking a year-over-year decrease of 1085.18%. This contributed to the annual value of $4.2 million for FY2025, which is 6552.4% up from last year.
  • According to the latest figures from Q4 2025, Mesa Laboratories' Capital Expenditures is $732000.0, which was down 996.31% from $1.1 million recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' Capital Expenditures ranged from a high of $2.1 million in Q4 2021 and a low of $225000.0 during Q2 2022
  • Over the past 5 years, Mesa Laboratories' median Capital Expenditures value was $914500.0 (recorded in 2021), while the average stood at $983150.0.
  • Per our database at Business Quant, Mesa Laboratories' Capital Expenditures surged by 73360.32% in 2021 and then tumbled by 6554.36% in 2022.
  • Over the past 5 years, Mesa Laboratories' Capital Expenditures (Quarter) stood at $2.1 million in 2021, then decreased by 19.67% to $1.7 million in 2022, then plummeted by 31.8% to $1.1 million in 2023, then fell by 27.93% to $813000.0 in 2024, then decreased by 9.96% to $732000.0 in 2025.
  • Its Capital Expenditures was $732000.0 in Q4 2025, compared to $1.1 million in Q3 2025 and $1.0 million in Q2 2025.